(100 days)
No
The summary describes standard physiological signal processing and analysis for alarm conditions, with no mention of AI or ML techniques.
No
This device monitors and records physiological parameters, provides alarms for excursions, but does not state that it treats any medical condition or directly restores health.
No
Explanation: The PM-7000 Patient Monitor is explicitly described as being "intended to be used for monitoring, recording, and alarming of multiple physiological parameters." While it detects and analyzes parameters like arrhythmia and ST segments, its stated purpose is to monitor and notify, not to diagnose a specific condition or disease. The "Indications for Use" section focuses on monitoring and the device description outlines data acquisition and alarming, not diagnostic outputs or interpretations.
No
The device description explicitly states it is a "battery or line-powered patient monitor" that "acquire[s] the physiological signals" and has a "color TFT display," "optional built-in recorder," and "optional CF memory card." These are all hardware components, indicating it is not a software-only device.
Based on the provided information, this device is not an In Vitro Diagnostic (IVD).
Here's why:
- IVDs analyze samples taken from the body (in vitro - "in glass"). This device directly monitors physiological parameters within the patient's body (in vivo - "in the living").
- The intended use and device description clearly state it monitors physiological signals directly from the patient. This includes things like ECG, blood pressure, SpO2, temperature, etc. These are all measurements taken from the living patient, not from a sample in a lab.
- There is no mention of analyzing biological samples like blood, urine, tissue, etc.
Therefore, the PM-7000 Patient Monitor is a patient monitoring device, not an IVD.
N/A
Intended Use / Indications for Use
The PM-7000 Patient Monitor is intended to be used for monitoring, recording, and alarming of multiple physiological parameters in health care facilities by qualified health care professionals trained in the use of the equipment.
The physiological parameters that can be monitored by the PM-7000 Patient Monitor are: ECG(3-lead or 5-lead or 12-lead selectable), arrhythmia detection, ST Segment analysis, Heart Rate(HR), Respiration Rate(RESP), Non-invasive Blood Pressure (NIBP), Pulse Oxygen Saturation (SpO2), Temperature (TEMP), Invasive Blood Pressure(IBP), Pulse Rate(PR), Carbon Dioxide (CO2), and Anaesthetic Gases(AG).
Its design allows the operator to adjust the settings of parameter alarms that audibly and visually notify the operator when an excursion occurs.
The target populations are human patients ranging from adult to neonate with the exception of the arrhythmia detection and ST Segment analysis, for which the target populations are adult and pediatric only.
The Monitor is not intended for use in a patient's home or residence, or when it has not been ordered by a physician.
Product codes (comma separated list FDA assigned to the subject device)
MHX
Device Description
The PM-7000 Patient Monitor is battery or line-powered patient monitor. The patient monitor acquire the physiological signals such as ECG respiration (RESP), non-invasive blood pressure (NIBP), saturation of pulse oxygen (SpO2), temperature (TEMP), invasive pressure (IBP), carbon dioxide (CO2) and anaesthetic gases (AG). These physiological signals are converted into digital data and processed. The monitor examines the data for alarm conditions and presents them on the color TFT display. The monitor also provides advantageous operating control for the user. The optional built-in recorder, the optional CF memory card provides hard copies of all digital data and waveforms as well as tabular and graphic trend information, and storage the previous monitoring data information when power off accidentally.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
human patients ranging from adult to neonate with the exception of the arrhythmia detection and ST Segment analysis, for which the target populations are adult and pediatric only.
Intended User / Care Setting
qualified health care professionals trained in the use of the equipment. in health care facilities. The Monitor is not intended for use in a patient's home or residence, or when it has not been ordered by a physician.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
By risk analysis, verification and validation caused by differences between PM-7000 and PM-9000 Express have been completely conducted according to testing methods that have been cleared in PM-9000 Express (K070791).
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.1025 Arrhythmia detector and alarm (including ST-segment measurement and alarm).
(a)
Identification. The arrhythmia detector and alarm device monitors an electrocardiogram and is designed to produce a visible or audible signal or alarm when atrial or ventricular arrhythmia, such as premature contraction or ventricular fibrillation, occurs.(b)
Classification. Class II (special controls). The guidance document entitled “Class II Special Controls Guidance Document: Arrhythmia Detector and Alarm” will serve as the special control. See § 870.1 for the availability of this guidance document.
0
510(K) SUMMARY
This summary of 510(k) safety and effectiveness information is submitted in accordance with the requirements of SMDA 1990 and 21 CFR §807.92.
The assigned 510(k) number is:
Submitter:
Shenzhen Mindray Bio-medical Electronics Co., LTD Mindray Building, Keji 12th Road South, Hi-tech Industrial Park, Nanshan, Shenzhen, 518057, P. R. China
Tel: +86 755 2658 2888 Fax: +86 755 2658 2680
NOV 2 9 2007
- Contact Person: .
Li Dongling
Shenzhen Mindray Bio-medical Electronics Co., LTD Mindray Building, Keji 12th Road South, Hi-tech Industrial Park, Nanshan, Shenzhen, 518057, P. R. China
Date Prepared: .
August 8, 2007
Name of the devices:
- Trade/Proprietary Name: PM-7000 Patient Monitor ●
- Common Name: Patient Monitor .
- Classification ●
| 21 CFR 870.1025 Arrhythmia detector and alarm
| (including ST-segment measurement and alarm) | Class II |
|---|---|
| 21 CFR 870.1025 Detector and Alarm, Arrhythmia | Class II |
| 21 CFR 870.1025 Monitor, ST Segment with Alarm | Class II |
| 21 CFR 870.2300 Cardiac monitor (including cardiotachometer and rate alarm) | Class II |
| 21 CFR 870.1130 Non-Invasive blood pressure measurement System | Class II |
| 21 CFR 870.1110 Blood pressure computer | Class II |
| 21 CFR 870.2900 Cable, transducer and electrode, patient, (including connector) | Class II |
| 21 CFR 880.2910 Clinical Electronic Thermometers - | Class II |
Page 1 of 3
1
| Temperature Monitor with Probe | Class II | |
|---|---|---|
| 21 CFR 870.2700 | Oximeter, Pulse | Class II |
| 21 CFR 870.2710 | Ear Oximeter, Pulse | Class II |
| 21 CFR 868.1400 | Carbon Dioxide Gas Analyzer | Class II |
| 21 CFR 868.1500 | Enflurane gas analyzer | Class II |
| 21 CFR 868.1500 | analyzer, gas, desflurane, gaseous-phase | |
| (anesthetic concentration) | Class II | |
| 21 CFR 868.1500 | analyzer, gas, sevoflurane, gaseous-phase | |
| (anesthetic concentration) | Class II | |
| 21 CFR 868.1500 | analyzer, gas, isoflurane, gaseous-phase | |
| (anesthetic concentration) | Class II | |
| 21 CFR 868.1620 | Halothane gas analyzer | Class II |
| 21 CFR 868.1700 | Nitrous Oxide gas analyzer | Class II |
| 21 CFR 868.1720 | Oxygen gas analyzer | Class II |
Legally Marketed Predicate Devices:
PM Series Patient Monitors, Model PM-9000 Express, SHENZHEN K#070791, MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
Description:
The PM-7000 Patient Monitor is battery or line-powered patient monitor. The patient monitor acquire the physiological signals such as ECG respiration (RESP), non-invasive blood pressure (NIBP), saturation of pulse oxygen (SpO2), temperature (TEMP), invasive pressure (IBP), carbon dioxide (CO2) and anaesthetic gases (AG). These physiological signals are converted into digital data and processed. The monitor examines the data for alarm conditions and presents them on the color TFT display. The monitor also provides advantageous operating control for the user. The optional built-in recorder, the optional CF memory card provides hard copies of all digital data and waveforms as well as tabular and graphic trend information, and storage the previous monitoring data information when power off accidentally.
Statement of intended Use:
The PM-7000 Patient Monitor is intended to be used for monitoring, recording, and alarming of multiple physiological parameters in health care facilities by qualified health care professionals trained in the use of the equipment.
The physiological parameters that can be monitored by the PM-7000 Patient Monitor are: ECG(3-lead or 5-lead or 12-lead selectable), arrhythmia detection, ST Segment analysis, Heart Rate(HR), Respiration Rate(RESP), Non-invasive Blood Pressure (NIBP), Pulse
2
Oxygen Saturation (SpO2), Temperature (TEMP), Invasive Blood Pressure(IBP), Pulse Rate(PR), Carbon Dioxide (CO2), and Anaesthetic Gases(AG).
Its design allows the operator to adjust the settings of parameter alarms that audibly and visually notify the operator when an excursion occurs.
The target populations are human patients ranging from adult to neonate with the exception of the arrhythmia detection and ST Segment analysis, for which the target populations are adult and pediatric only.
The Monitor is not intended for use in a patient's home or residence, or when it has not been ordered by a physician.
Comparison of Technological Characteristics:
Both the PM-7000 Patient Monitor and the predicate PM-9000 Express Patient Monitor (K070791) have the same parameters modules, measurement accessories and modules (software/hardware). That is to say, they have identical parameters subsystems. Both the devices have the main board and host software in common, and identical screen layout (user interface and display style). Parameter measurement performance and function specification of PM-7000 could be proved by the verification and validation of PM-9000 Express (K070791) because both are ensured by same modules and same software.
There are differences only in power supply, key board, and display Screen. The technological differences do not affect the safety or efficacy of the devices. And safety and effectives of PM-7000 could be ensured by the same design control procedure as PM-9000 Express.
Testing:
By risk analysis, verification and validation caused by differences between PM-7000 and PM-9000 Express have been completely conducted according to testing methods that have been cleared in PM-9000 Express (K070791).
Conclusion:
The PM-7000 Patient Monitor is as safe, as effective, and performs as well as the legally marketed predicate device PM Series Patient Monitors, Model PM-9000 Express (K070791).
3
DEPARTMENT OF HEALTH & HUMAN SERVICES
Public Health Service
Image /page/3/Picture/2 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a stylized image of three human profiles facing to the right. The profiles are stacked on top of each other, with the top profile being the most complete and the bottom profile being the least complete. The logo is surrounded by the text "DEPARTMENT OF HEALTH & HUMAN SERVICES-USA" in a circular pattern.
NOV 2 9 2007
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
Shenzhen Mindray Bio-Medical Electronics Co. Ltd. c/o Ms. Susan D. Goldstein-Falk mdi Consultants, Inc. 55 Northern Blvd., Suite 200 Great Neck, New York 11021
Re: K072346
Trade/Device Name: PM-7000 Patient Monitor Regulation Number: 21 CFR 870.1025 Regulation Name: Arrhythmia Detector and Alarm (Including ST-Segment Measurement and Alarm) Regulatory Class: Class II (two) Product Code: MHX Dated: November 1, 2007 Received: November 2, 2007
Dear Ms. Goldstein-Falk:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
4
Page 2 - Ms. Susan D. Goldstein-Falk
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely vours.
Blymmumor for
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
Indications for Use
072346
510(k) Number (if known):
Device Name: PM-7000 Patient Monitor
Indications for Use:
The PM-7000 Patient Monitor is intended to be used for monitoring, recording, and alarming of multiple physiological parameters in health care facilities by qualified health care professionals trained in the use of the equipment.
The physiological parameters that can be monitored by the PM-7000 Patient Monitor are: ECG(3-lead or 5-lead or 12-lead selectable), arrhythmia detection, ST Segment analysis, Heart Rate(HR), Respiration Rate(RESP), Non-invasive Blood Pressure (NIBP), Pulse Oxygen Saturation (SpO₂), Temperature (TEMP), Invasive Blood Pressure(IBP), Pulse Rate(PR), Carbon Dioxide (CO2), and Anaesthetic Gases(AG).
Its design allows the operator to adjust the settings of parameter alarms that audibly and visually notify the operator when an excursion occurs.
The target populations are human patients ranging from adult to neonate with the exception of the arrhythmia detection and ST Segment analysis, for which the target populations are adult and pediatric only.
The Monitor is not intended for use in a patient's home or residence, or when it has not been ordered by a physician.
Prescription Use X (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Page ot
Bymmamo